PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

How 'phenotype switching' can make melanoma become metastatic and resistant to drugs

By understanding the Wnt5A signaling pathway, researchers may be able to determine which patients may respond more favorably to BRAF inhibitors

2013-10-19
(Press-News.org) Contact information: Ben Leach
bleach@wistar.org
215-495-6800
The Wistar Institute
How 'phenotype switching' can make melanoma become metastatic and resistant to drugs By understanding the Wnt5A signaling pathway, researchers may be able to determine which patients may respond more favorably to BRAF inhibitors One of the challenges of understanding cancer is trying to determine the mechanisms that drive metastasis, or the process by which tumor cells are able to spread throughout the body. In order to investigate metastasis, researchers at The Wistar Institute focused on a process involving the phenotypes – the outward, physical appearance based on genetic coding – of tumor cells. According to the researchers, "phenotype switching" may be involved in changing appearance of melanoma tumors by altering the number and type of protein receptors that dot the surface of the individual melanoma cells within the tumor. Identifying the phenotype patients exhibit may help determine which patients are more likely to benefit from existing medications while also providing an opportunity to create new targeted therapies.

The findings were published in the journal Cancer Discovery and are currently available online.

"We were able to demonstrate for the first time that different receptors within a single signaling pathway – in this case, the Wnt signaling pathway – can guide the phenotypic plasticity of tumor cells, and increased signaling of Wnt5A in particular can result in an increase in highly invasive tumor cells that are less sensitive to existing treatments for metastatic melanoma," said Ashani Weeraratna, Ph.D., assistant professor in the Tumor Microenvironment and Metastasis Program of Wistar's NCI-designated Cancer Center, and senior corresponding author on the manuscript.

While melanoma accounts for less than 5 percent of all cases of skin cancer, it is the deadliest form of the disease, resulting in a large majority of all the deaths related to skin cancer, according to the American Cancer Society. The five-year survival rate for patients with metastatic melanoma is between 15 and 20 percent, and while new, targeted therapies designed to combat the disease based on a person's genetics have become available in recent years, some of these drugs are not particularly effective in many patients, and many who do respond well to the drugs often eventually become resistant to them. This makes understanding advanced stages of melanoma and what internal processes could be at work all the more important for developing new treatments. Weeraratna and her team focus on Wnt5A, a Wnt signaling molecule that has been found in increased levels in metastatic melanomas. In order for Wnt5A to promote the phenotype switch from early in the tumor's formation to the time it becomes metastatic, the tyrosine kinase receptor ROR2 is required. When ROR2 is not present, Wnt5A is unable to promote tumor metastasis. The only other member of the family that has been identified is ROR1, and this research was done to determine what role ROR1 might play in the progression of melanoma. The researchers were able to determine that ROR1 inhibited the invasion of melanoma cells, and this receptor was targeted for degradation by Wnt5A and ROR2. When ROR1 was silenced, the researchers observed that there was an increased rate of invasion of melanoma cells both in vitro and in vivo. The researchers also found that hypoxia – areas of low oxygen supply in the tumor – is able to induce a switch from ROR1 to ROR2 and results in an increase in levels of Wnt5A, suggesting the switch from a non-invasive ROR1-positive phenotype to an invasive ROR2-positive phenotype occurs when the tumor is exposed to hypoxic conditions. The researchers also found that a protein HIF1α is required to increase the Wnt5A expressed. When HIF1α was removed, ROR2 was decreased, indicating that the upregulation of ROR2 via HIF1α requires Wnt5A. To determine the clinical implications, the researchers hypothesized that melanoma cells driven by the mutant BRAF gene that were also high in Wnt5A might be less sensitive to treatment with vemurafenib, a drug approved by the FDA in 2011 for the treatment of BRAF-positive metastatic melanoma. By measuring BRAF cell lines to determine their Wnt5A and ROR2 status, as well as their sensitivity to BRAF inhibitors, the researchers found a significant correlation between BRAF inhibitor resistance and Wnt5A expression. Additionally, in a small cohort of patients, they found that seven out of nine patients who demonstrated less than a 33 percent clinical response to vemurafenib had a positive expression of Wnt5A, and only two of the remaining 15 patients who had a 38% or greater clinical response to vemurafenib exhibited any Wnt5A expression. When they silenced ROR2 in tumors xenografted in mice, the tumors responded far better to simultaneous treatment with the BRAF inhibitor vemurafenib. Conversely, when ROR1 was silenced, the tumors became more resistant to the drug. Additionally, in eight patients who had undergone BRAF inhibitor therapy, the levels of Wnt5A were much lower in tumor cells prior to therapy compared to cells that were tested for Wnt5A after those same patients had relapsed. "By using Wnt5A as a biomarker, we could determine which patients are likely to respond better to therapy with vemurafenib and help prolong that response," Weeraratna said. "There is also the potential to explore small molecule inhibitors of ROR2, since there is now a clear association between that and the ability of melanoma to become not only metastatic, but also therapy-resistant. This link between metastasis and therapy resistance is what we find the most exciting and intriguing, as therapies designed to target one process may have a significant impact on the other as well. " ### The co-authors of the study are members of the Tumor Metastasis and Microenvironment Program and the Molecular and Cellular Oncogenesis Program at Wistar. They include Michael P. O'Connell,Ph.D.; Katie Marchbank, Ph.D.; Marie R. Webster, Ph.D.; Alexander A. Valiga; Amanpreet Kaur; Adina Vultur, Ph.D.; Ling Li, M.D.; Meenhard Herlyn, D.Vm., D.Sc.; and Sandy Widura in the Tumor Metastasis and Microenvironment Program, and Jessie Villanueva, Ph.D.; Qin Liu, M.D., Ph.D.; and Xiangfan Yin in the Molecular Cellular Oncogenesis Program. O'Connell is the lead author of the study. The researchers also collaborated with the National Institute on Aging of the National Institutes of Health; Dana Farber/Harvard Cancer Center; the Lehigh Valley Health Network; and the Abramson Cancer Center of the University of Pennsylvania. This study was made possible in part by grants from the National Institute on Aging Intramural Research Program, the PA Department of Health (CURE) funding, and the Joanna M. Nicolay Foundation.


ELSE PRESS RELEASES FROM THIS DATE:

Paramedics' visits with seniors result in less EMS calls and saves on emergency room trips

2013-10-19
Paramedics' visits with seniors result in less EMS calls and saves on emergency room trips Community health awareness delivered by paramedics leads to 32 percent reduction in EMS calls Montreal - Emergency Medical Service (EMS) staff are ...

Market bubbles may be predictable, controllable

2013-10-18
Market bubbles may be predictable, controllable Chaos-on-a-chip model shows crash can be avoided if caught in time DURHAM, N.C. -- It's an idea financial regulators have dreamed of. Experiments on a simple model of chaos have found that it may be possible not only to ...

A new look at air pollution sources and atmosphere-warming particles in South Asia

2013-10-18
A new look at air pollution sources and atmosphere-warming particles in South Asia DRI study provides first thorough analysis of emissions from outdoor cremation rituals (RENO): When Rajan Chakrabarty, Ph.D., an assistant research professor at the Desert ...

Challenges and opportunities for reducing antibiotic resistance in agricultural settings

2013-10-18
Challenges and opportunities for reducing antibiotic resistance in agricultural settings October 17, 2013—Antibiotic resistance (ABR) has been around for millennia; genes showing ABR have been found in woolly mammoth fossils. It's a natural occurrence, ...

New study finds spike in sugary drink consumption among California adolescents

2013-10-18
New study finds spike in sugary drink consumption among California adolescents While consumption of soda and other sugary drinks among young children in California is starting to decline, a new study released today shows an alarming 8 percent spike ...

Habitat research methods give a new peek at tiger life with conservation

2013-10-18
Habitat research methods give a new peek at tiger life with conservation From a tiger's point of view, yesterday's thoughtful conservation plans might be today's reason to branch out. An international team of researchers has found a useful way to better understand ...

Learning dialects shapes brain areas that process spoken language

2013-10-18
Learning dialects shapes brain areas that process spoken language Using advanced imaging to visualize brain areas used for understanding language in native Japanese speakers, a new study from the RIKEN Brain Science Institute finds that the pitch-accent in words pronounced in standard Japanese activates ...

Scientists identify key genes for increasing oil content in plant leaves

2013-10-18
Scientists identify key genes for increasing oil content in plant leaves Accumulating oil in leaves could significantly increase energy content of biofuels and plant-based foods UPTON, NY -- Scientists at the U.S. Department of Energy's Brookhaven ...

Tiny sea creatures are heading for extinction, and could take local fisheries with them

2013-10-18
Tiny sea creatures are heading for extinction, and could take local fisheries with them A species of one of the world's tiniest creatures, ocean plankton, is heading for extinction as it struggles to adapt to changes in sea temperature. And it may take ...

Oral nutritional supplements may help hospitals achieve readmission reduction policies

2013-10-18
Oral nutritional supplements may help hospitals achieve readmission reduction policies As Affordable Care Act penalties on hospital readmissions increase, nutritional intervention may help decrease 30-day readmission rates among Medicare patients In the U.S., one ...

LAST 30 PRESS RELEASES:

Cold atoms on a chip

Rice University study reveals how rising temperatures could lead to population crashes

WVU research reveals adults with disabilities misuse prescription drugs at high rates

Consumers value domestic vanilla -- when informed, research shows

Are higher doses of folic acid in pregnancy safe?

Survey confirms radiation and orthopedic health hazards in cardiac catheterization laboratories are ‘unacceptable’

Study finds consumer devices can be used to assess brain health

Teachers' negative emotions impact engagement of students, new study finds

Researchers see breakthrough with biofuel

White blood cells use brute force to dislodge bacteria

Foundation AI model predicts postoperative risks from clinical notes

Brain functional networks adapt in response to surgery and Botox for facial palsy

Multimodal AI tool supports ecological applications

New University of Minnesota research shows impact of anxiety and apathy on decision-making

Fred Hutch announces 10 recipients of the 2025 Harold M. Weintraub Graduate Student Award

30 million euros for a novel method of monitoring the world's oceans and coastal regions using telecommunications cables

New multicenter study shows: Which treatment helps best with high-risk acute pulmonary embolism

Hidden dangers and myths: What you need to know about HPV and cancer

SNU researchers develop world’s first technology to observe atomic structural changes of nanoparticles in 3D

SNU researchers develop a new synthesis technology of single crystal 2D semiconductors, “Hypotaxy,” to enhance the commercialization of next-generation 2D semiconductors

Graphene production method offers green alternative to mining

Researchers discover a cause of leptin resistance—and how to reverse it

Heat from the sun affects seismic activity on Earth

Postoperative aspiration pneumonia among adults using GLP-1 receptor agonists

Perceived discrimination in health care settings and care delays in patients with diabetes and hypertension

Postoperative outcomes following preweekend surgery

Nearly 4 of 10 Americans report sports-related mistreatment

School absence patterns could ID children with chronic GI disorders, research suggests

Mount Sinai researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes

Study: Smartwatches could end the next pandemic

[Press-News.org] How 'phenotype switching' can make melanoma become metastatic and resistant to drugs
By understanding the Wnt5A signaling pathway, researchers may be able to determine which patients may respond more favorably to BRAF inhibitors